All Stories

  1. Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma
  2. Systemic treatments for hepatocellular carcinoma: challenges and future perspectives
  3. Prognostic significance of adverse events in patients with hepatocellular carcinoma treated with sorafenib
  4. c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma